• Sipuleucel-T Immunotherapy for Castration-Resistant Prostate ...

      www.nejm.org/doi/full/10.1056/NEJMoa1001294 Sipuleucel-T, an autologous active cellular immunotherapy, has shown evidence of efficacy in reducing the risk of death among men with metastatic castration-resistant ...
    • PROVENGE - Dendreon.com

      www.dendreon.com/products/provenge PROVENGE PROVENGE ® (sipuleucel-T) Is FDA Approved. PROVENGE is the first and only FDA approved immunotherapy IMMUNOTHERAPY Treatment that helps the immune system ...
    • PROVENGE (sipuleucel-T)

      www.fda.gov/BiologicsBloodVaccines/CellularGeneTherapyProducts/.../ucm210012.htm April 29, 2010 Approval Letter - Provenge Indication: For the treatment of asymptomatic or minimally symptomatic metastatic castrate resistant (hormone refractory ...